| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |